Back to top

Truist Financial Remains a Buy on Insmed (INSM)

In a report released today, Danielle Brill from Truist Financial reiterated a Buy rating on Insmed, with a price target of $195.00. Brill covers th...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Insmed, Inc. (INSM)